<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02028156</url>
  </required_header>
  <id_info>
    <org_study_id>DA06</org_study_id>
    <nct_id>NCT02028156</nct_id>
  </id_info>
  <brief_title>Feeding Intolerance in Formula-Fed Infants</brief_title>
  <official_title>Evaluation of Feeding Intolerance in Formula-Fed Infants: A Non-Randomized, Single-Group, Multi-Center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized, single-group, multi-center, two phased study to evaluate formula
      intolerance.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low enrollment
  </why_stopped>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Fussiness</measure>
    <time_frame>0 to 15 days</time_frame>
    <description>Study phase 2; Parent completed questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diarrhea</measure>
    <time_frame>0 to 4 weeks</time_frame>
    <description>Study phase 1; Parent completed questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation</measure>
    <time_frame>0 to 4 weeks</time_frame>
    <description>Study phase 1; Parent completed questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spit-up</measure>
    <time_frame>0 to 4 weeks</time_frame>
    <description>Study phase 1; Parent completed questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gassiness</measure>
    <time_frame>0 to 4 weeks</time_frame>
    <description>Study phase 1; Parent completed questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Feeding Intolerance</condition>
  <arm_group>
    <arm_group_label>Partially Hydrolyzed Infant Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fed ad lib.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Partially Hydrolyzed Infant Formula</intervention_name>
    <description>Commercially available infant formula</description>
    <arm_group_label>Partially Hydrolyzed Infant Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion Criteria for Stage 1:

          -  Singleton full term birth with birth weight of &gt; 2500g.

          -  Infant between 0 and 60 days of age.

          -  Discontinuation of medications that might affect gastrointestinal (GI) tolerance.

          -  Infant is exclusively formula-fed a full-lactose, intact cow milk protein-based infant
             formula (CMF) for less than 7 days prior to enrollment.

        Inclusion Criteria for Stage 2:

          -  Infant was fed according to protocol in Stage 1 of the study.

          -  Infant was identified as being fussy using the Intolerance Assessment Tool in Stage 1.

        Exclusion Criteria:

        Exclusion Criteria for Stage 1:

          -  Chromosomal or major congenital anomalies.

          -  Suspected or known metabolic or physical diseases affecting infant feeding and/or
             metabolism.

          -  Hospitalization, other than for delivery, prior to enrollment.

          -  Severe uncontrolled eczema, visible bloody stools or milk protein allergy prior to
             enrollment.

          -  More than 1 substitution of an infant formula other than full-lactose, intact cow milk
             formula (CMF) since birth.

          -  Use of a prokinetic drug within 7 days before enrollment.

        Exclusion Criteria for Stage 2:

          -  Infant's intolerance symptom was caused by another reason, for example known
             infection/illness, food allergy, or response to vaccination(s).

          -  Infant has immunization(s) within 3 days of enrollment in Stage 2.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>60 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shirley Li, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guangdong Women and Children Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing Maternity and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xin Hua Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2013</study_first_submitted>
  <study_first_submitted_qc>January 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2014</study_first_posted>
  <last_update_submitted>November 5, 2014</last_update_submitted>
  <last_update_submitted_qc>November 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

